Belzutifan is a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors could boost incidence or severity of adverse consequences. Check for anemia and hypoxia and lessen belzutifan dose as proposed. modafinil will decrease the level or effect of norgestrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Average CYP3A4 inducers https://modafinil98764.theisblog.com/26297485/little-known-facts-about-modafinil